Sofwave Medical Ltd (SOFW) - Total Liabilities

Latest as of March 2026: ILA22.97 Million ILA ≈ $61.57K USD

Based on the latest financial reports, Sofwave Medical Ltd (SOFW) has total liabilities worth ILA22.97 Million ILA (≈ $61.57K USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore SOFW net assets growth trend to track the company's year-over-year net asset growth rate.

Sofwave Medical Ltd - Total Liabilities Trend (2018–2025)

This chart illustrates how Sofwave Medical Ltd's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Sofwave Medical Ltd to measure how efficiently the company converts operating cash flow to free cash.

Sofwave Medical Ltd Competitors by Total Liabilities

The table below lists competitors of Sofwave Medical Ltd ranked by their total liabilities.

Company Country Total Liabilities
Guangdong VTR Bio-Tech Co Ltd
SHE:300381
China CN¥266.84 Million
KKR Real Estate Finance Trust Inc
NYSE:KREF
USA $5.80 Billion
Canopy Growth Corp
TO:WEED
Canada CA$348.02 Million
Beijing Zhongkehaixun Digital S T
SHE:300810
China CN¥472.24 Million
SGC Energy Co Ltd
KO:005090
Korea ₩2.53 Trillion
Banco Santander Brasil SA
BA:BSBR
Argentina AR$1.17 Trillion
Shenzhen Ellassay Fashion Co
SHG:603808
China CN¥1.19 Billion
Hes Technology Group
SHE:002963
China CN¥396.92 Million

Liability Composition Analysis (2018–2025)

This chart breaks down Sofwave Medical Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Sofwave Medical Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.43 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.65 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.39 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sofwave Medical Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sofwave Medical Ltd (2018–2025)

The table below shows the annual total liabilities of Sofwave Medical Ltd from 2018 to 2025.

Year Total Liabilities Change
2025-12-31 ILA23.06 Million
≈ $61.84K
+24.65%
2024-12-31 ILA18.50 Million
≈ $49.61K
+7.62%
2023-12-31 ILA17.19 Million
≈ $46.09K
+25.15%
2022-12-31 ILA13.74 Million
≈ $36.83K
-2.34%
2021-12-31 ILA14.07 Million
≈ $37.71K
+327.96%
2020-12-31 ILA3.29 Million
≈ $8.81K
+55.41%
2019-12-31 ILA2.12 Million
≈ $5.67K
+73.79%
2018-12-31 ILA1.22 Million
≈ $3.26K
--

About Sofwave Medical Ltd

TA:SOFW Israel Medical Devices
Market Cap
$415.96 Million
ILA155.15 Billion ILA
Market Cap Rank
#13186 Global
#148 in Israel
Share Price
ILA4294.00
Change (1 day)
-0.69%
52-Week Range
ILA2356.00 - ILA4744.00
All Time High
ILA4744.00
About

SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and … Read more